3D BioFibR, a Halifax, Canada-based company which specializes in advancing biomaterials for tissue engineering, raised $3.52M in Seed funding.
The round was led by Invest Nova Scotia with participation from Build Ventures and returning investors Concrete Ventures and Globalive Capital.
The company intends to use the funds to expand its facilities to include a climate controlled biomanufacturing cleanroom and bring its collagen fiber products to market.
Led by CEO Kevin Sullivan, 3D BioFibR produces collagen fibers at commercial scales for a variety of tissue engineering and medical applications. Its proprietary dry-spinning process produces fibers that are recreating the natural appearance, structure, and function of collagen fibers. This manufacturing process makes its collagen fibers accessible for an increasing number of biomedical applications in the growing tissue engineering market.
FinSMEs
20/07/2023